⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Stem Cell Exhaustion and Stem Cell-Based Interventions
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-28 — Enhancing the anti-ageing capacity of hUC-MSCs via NMN co-treatment in D-galactose-induced ageing mice and cellular senescence models.: cross-connection with nampt-nad-biosynthesis: NMN pretreatment of hUC-MSCs reduces post-transplant stem-cell senescence and improves anti-aging efficacy in D-galactose mice, linking NAD-precursor availability to the longevity of exogenous MSC grafts. (novelty: 3)
- 2026-05-20 — Single-cell multiomics gene regulatory landscape reveals impaired spermatogonial stem cells and macrophage-driven inflammaging during testicular aging.: cross-connection with testicular-aging-ssc-macrophage-axis: Adds the spermatogonial stem cell compartment to the organ-resolved stem-cell exhaustion roster with chromatin-accessibility and transcription-factor-level (ZFX) readouts. (novelty: 3)
- 2026-09-28 — Stress-Induced Senescence of Human Umbilical Cord Mesenchymal Stromal Cells Caused by Mitomycin C.: cross-connection with cellular-senescence: Perinatal UC-MSCs undergo p53/p21/p27 proliferation arrest without a classical senescent phenotype under mitomycin C, nominating developmental origin (perinatal vs adult stromal cells) as a determinant of whether DDR-triggered arrest in therapeutic MSC products converts to full senescence — relevant to MSC-based intervention manufacturing where senescence entry degrades product potency. (novelty: 3)
- 2026-07-18 — GLP1 Mimetics and Stem Cells: An Intersection of Metabolic and Regenerative Medicine.: 2026 editorial review proposes GLP-1 receptor agonists may modulate embryonic/adult stem-cell proliferation, survival, differentiation and stemness relevant to tissue regeneration; synthesis of heterogeneous preclinical data, no new primary findings and no human regenerative endpoints. [expert-opinion] (novelty: 3)
- 2026-09-23 — Targeting BIRC6 rejuvenates hematopoietic stem cell aging and immunosenescence.: cross-connection with hsc-aging-birc6: Reframes HSC ‘exhaustion’ partly as apoptosis resistance driven by BIRC6 upregulation rather than pure functional decline, and offers a targeted pharmacological reversal handle. (novelty: 4)
Open questions
Related
Contributing findings
Satellite cell attrition and skeletal muscle aging.
13-nov-2026
novelty 2
per-area 2
strengthens
A Mechanism‐Based Framework for Anti‐Aging Strategies: From Metabolic Regulation to Senotherapy and Stem Cell‐Based Interventions
28-aug-2026
novelty 2
per-area 2
mentions
GLP1 Mimetics and Stem Cells: An Intersection of Metabolic and Regenerative Medicine.
18-jul-2026
novelty 3
per-area 3
strengthens